Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Conference Correspondent
ASCO 2015
ASCO 2015 Highlights
NCCN Awards 5 Grants to Study Afatinib Efficacy in Several Solid Tumors
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
Physical Activity Can Lower Risk of Invasive Breast Cancer
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
A New Molecular Cervical Cancer Test Will Aid Accurate Diagnosis
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Quest Diagnostics, the leading provider of diagnostic testing, has introduced a new laboratory test that identifies molecular changes to cervical cells that may signal increased risk for cervical cancer.
Read Article
The Number of Cancer Survivors on the Rise in the United States
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
Afinitor Gets the Nod for Metastatic Breast Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read Article
Carfilzomib Added to Multiple Myeloma Therapies
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read Article
Zaltrap Newest Drug for Metastatic Colorectal Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read Article
FDA Expedited Approval of Xtandi for Prostate Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read Article
Bosulif Approved for Ph+ CML
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read Article
Economics Impede Growth of Supportive Care Services
By
Phoebe Starr
Economics & Value
,
Economics of Cancer Care
,
MASCC Symposium
September 2012, Vol 3, No 6
New York, NY—Supportive care is effective in improving outcomes, but the growth of supportive care programs is hampered by economics, explained Eduardo Bruera, MD, Chair, Palliative Care & Rehabilitation Medicine, University of Texas M.D. Anderson Cancer Center, Houston, speaking at the 2012 Multinational Association of Supportive Care in Cancer International Symposium.
Read Article
Page 282 of 330
279
280
281
282
283
284
285
Top Trending Articles
1.
FDA Approves Acalabrutinib and Venetoclax Combination for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
2.
FDA Launches Unified Adverse Event Monitoring System to Enhance Transparency and Efficiency
3.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma